InMed Pharmaceuticals Inc. Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2024 | 1 | $2.14 | $2.14 | $2.14 |
| Q2 2024 | 1 | $1.83 | $1.83 | $1.83 |
| Q3 2024 | 1 | $2.09 | $2.09 | $2.09 |
InMed Pharmaceuticals Inc. Earnings Date And Information
InMed Pharmaceuticals Inc. last posted its earnings results on Friday, February 17th, 2023. The company reported $-0.91 earnings per share for the quarter, topping analysts' consensus estimates of $-4.5 by $3.59. The company had revenue of 2.04 B for the quarter and had revenue of 4.60 M for the year. InMed Pharmaceuticals Inc. has generated $-1 earnings per share over the last year ($-1.01 diluted earnings per share) and currently has a price-to-earnings ratio of -1.6. InMed Pharmaceuticals Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, November 12th, 2024 based on prior year's report dates.
InMed Pharmaceuticals Inc. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 11/14/2024 | Q1 2025 | -$2.71 | $2.04 B | $2.04 B | ||
| 09/27/2024 | Q4 2024 | -$0.00 | $2.44 M | $1.28 M | ||
| 05/13/2024 | Q3 2024 | -$0.18 | $1.17 M | |||
| 02/13/2024 | Q2 2024 | -$0.19 | $1.24 M | |||
| 11/13/2023 | Q1 2024 | -$0.76 | $1.88 M | $1.69 M | ||
| 12/21/2023 | Q4 2023 | -$0.10 | $1.73 M | $2.31 M | ||
| 05/15/2023 | Q3 2023 | -$0.60 | $1.03 M | |||
| 02/17/2023 | Q2 2023 | -$4.50 | -$0.91 | 3.59 | $469,783 | |
| 11/14/2022 | Q1 2023 | -$4.06 | $685,412 | $320,788 | ||
| 09/23/2022 | Q4 2022 | -$5.50 | -$12.22 | -6.72 | $965,678 | $514,758 |
| 05/13/2022 | Q3 2022 | -$5.75 | -$6.14 | -0.39 | $309,585 | |
| 02/14/2022 | Q2 2022 | -$6.00 | -$7.73 | -1.73 | $265,092 | |
| 11/10/2021 | Q1 2022 | -$8.75 | -$6.17 | 2.58 | $380,125 | $0 |
| 09/24/2021 | Q4 2021 | -$8.50 | -$10.13 | -1.63 | $0 | |
| 05/13/2021 | Q3 2021 | -$6.00 | -$10.27 | -4.27 | $0 | |
| 02/11/2021 | Q2 2021 | -$6.00 | -$9.21 | -3.21 | $0 | |
| 12/16/2020 | Q1 2021 | -$7.66 | $0 | |||
| 06/30/2020 | Q4 2020 | -$9.32 | $0 | |||
| 03/31/2020 | Q3 2020 | -$9.69 | $0 | |||
| 12/31/2019 | Q2 2020 | -$11.94 | $0 |
InMed Pharmaceuticals Inc. Earnings: Frequently Asked Questions
-
When is InMed Pharmaceuticals Inc.'s earnings date?
InMed Pharmaceuticals Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, November 12th, 2024 based off last year's report dates.
-
Did InMed Pharmaceuticals Inc. beat their earnings estimates last quarter?
In the previous quarter, InMed Pharmaceuticals Inc. (:INM) reported $-0.91 earnings per share (EPS) to beat the analysts' consensus estimate of $-4.5 by $3.59.
-
How can I listen to InMed Pharmaceuticals Inc.'s earnings conference call?
The conference call for InMed Pharmaceuticals Inc.'s latest earnings report can be listened to online.
-
How can I read InMed Pharmaceuticals Inc.'s conference call transcript?
The conference call transcript for InMed Pharmaceuticals Inc.'s latest earnings report can be read online.
-
How much revenue does InMed Pharmaceuticals Inc. generate each year?
InMed Pharmaceuticals Inc. (:INM) has a recorded annual revenue of $4.60 M.
-
How much profit does InMed Pharmaceuticals Inc. generate each year?
InMed Pharmaceuticals Inc. (:INM) has a recorded net income of $4.60 M. InMed Pharmaceuticals Inc. has generated $-1.01 earnings per share over the last four quarters.
-
What is InMed Pharmaceuticals Inc.'s price-to-earnings ratio?
InMed Pharmaceuticals Inc. (:INM) has a price-to-earnings ratio of -1.6 and price/earnings-to-growth ratio is 0.04.
